Anemia Clinical Trial
Official title:
Creating Homestead Agriculture for Nutrition and Gender Equity in Burkina Faso
The purpose of this study is to assess the long-term impact of the Enhanced Homestead Food Production Program implemented by HKI on household food security and nutritional status, as well as the impact on including additional interventions (BCC on WASH and malaria prevention, distribution of preventive lipid-based nutrient supplements (LNS)) to children aged 6-24 months old, in addition to the standard E-HFP model.
Over the past twenty years, Helen Keller International (HKI) has implemented its Homestead
Food Production (HFP) program to increase household production of micronutrient-rich foods
and improve the quality of diets among vulnerable households across Asia and, more recently,
Africa. As part of the program, village model farms -which support diversified, year-round
production of micronutrient-rich crops, and improved breeds of poultry and small animals-are
established to demonstrate gardening and small animal-raising techniques to program
participants. Program participants in turn are established to demonstrate gardening and
small animal-raising techniques to program participants. Program participants in turn are
provided with small inputs such as seeds, seedlings, and small tools to establish home
gardens using techniques they learn at the village model farms. In addition, the program
uses a behavior change communication (BCC) strategy to increase participant's health and
nutrition-related knowledge and practices.
In 2010, HKI introduced an enhanced-HFP (E-HFP) model in the Gourma province of Burkina Faso
with support from the USAID. The project used a randomized cluster design to assess the
impact of HKI's package of interventions on 1,200 beneficiary and 800 control children aged
3-12 months at baseline. Given the encouraging results of IFPRI's first evaluation of that
project, HKI is working to continue to improve and evaluate its E-HFP program in Burkina
Faso. Based on the recommendations from the initial evaluation in Burkina Faso, this
research aims to assess both the long-term impact of the E-HFP program as well as the impact
of including additional interventions, using the E-HFP platform to deliver these
interventions. The primary research questions that will be addresses will be:
- What is the relative impact of a long-term E-HFP program compared to a short-term E-HFP
program on household food security and child nutritional status?
- What is the impact of including additional messages and the promotion of practices
related to water, sanitation, hygiene, and malaria prevention (including bednet
utilization) in the BCC strategy, in addition to the standard E-HFP model?
- What is the impact of distributing preventive lipid-based nutrient supplements (LNS) to
children between the ages of 6-24 months in addition to participation in the E-HFP
program + additional messages and the promotion of practices related to water,
sanitation, hygiene, and malaria prevention (including bednet utilization)?
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Terminated |
NCT01535781 -
Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?
|
N/A | |
Completed |
NCT01458028 -
Age and Gender Effects on the Pharmacokinetics of BAY85-3934
|
Phase 1 |